Arena Pharmaceuticals Inc (NASDAQ:ARNA)
| 53.23 Delayed Data As of 4:00pm ET |  -0.71 / -1.32%Today’s Change | 42.48 Today|||52-Week Range 64.48 | +17.20% Year-to-Date |
Latest ARNA News | Press Releases
| FDA Asks That Weight Loss Drug Belviq Be Pulled From the Market Feb 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 53.94 |
| Today’s open | 53.70 |
| Day’s range | 52.53 - 54.28 |
| Volume | 352,848 |
| Average volume (3 months) | 411,120 |
| Market cap | $2.7B |
Data as of 4:00pm ET, 02/20/2020
Growth & Valuation
| Earnings growth (last year) | +76.88% |
| Earnings growth (this year) | +1,383.31% |
| Earnings growth (next 5 years) | -45.30% |
| Revenue growth (last year) | -15.78% |
| P/E ratio | 5.1 |
| Price/Sales | 101.96 |
| Price/Book | 4.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FOLDAmicus Therapeutics ... | +0.02 | +0.19% |
| BHVNBiohaven Pharmaceuti... | -0.40 | -0.86% |
| INSMInsmed Inc | -0.61 | -1.97% |
| TAROTaro Pharmaceutical ... | +0.45 | +0.62% |
Data as of 6:30pm ET, 02/20/2020
Financials
| Next reporting date | March 12, 2020 |
| EPS forecast (this quarter) | -$1.55 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$30.1M |
| Net profit margin | -158.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
